{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:33Z","timestamp":1790713773055,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":525,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/mt.2015.16","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T12:14:32Z","timestamp":1423224872000},"page":"835-844","source":"Crossref","is-referenced-by-count":64,"title":["Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Maria","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Eric","family":"M\u00e5nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 R A","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Mirzaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Ehinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Modlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.16_bib1","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.16_bib2","series-title":"The Metabolic & Molecular Basis of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1038\/mt.2015.16_bib3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/mt.2015.16_bib4","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","article-title":"Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease","volume":"87","author":"Barton","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.16_bib5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.16_bib6","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0010021","article-title":"Enzyme replacement in Gaucher disease","volume":"1","author":"Beutler","year":"2004","journal-title":"PLoS Med"},{"key":"10.1038\/mt.2015.16_bib7","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM199212033272304","article-title":"A less costly regimen of alglucerase to treat Gaucher's disease","volume":"327","author":"Figueroa","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.16_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1038\/mt.2015.16_bib9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00007890-199503000-00011","article-title":"Ten years\u2019 experience of bone marrow transplantation for Gaucher disease","volume":"59","author":"Ringd\u00e9n","year":"1995","journal-title":"Transplantation"},{"key":"10.1038\/mt.2015.16_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1005367328003","article-title":"Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase","volume":"20","author":"Young","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2015.16_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1038\/mt.2015.16_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mt.2015.16_bib13","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2015.16_bib14","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.16_bib15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.16_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","article-title":"Physiological promoters reduce the genotoxic risk of integrating gene vectors","volume":"16","author":"Zychlinski","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.16_bib17","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2007-01-068759","article-title":"Hot spots of retroviral integration in human CD34+ hematopoietic cells","volume":"110","author":"Cattoglio","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib18","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","article-title":"Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors","volume":"17","author":"Modlich","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.16_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1634\/stemcells.2008-0844","article-title":"Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease","volume":"27","author":"Enquist","year":"2009","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2015.16_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/hum.2009.141","article-title":"Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia","volume":"21","author":"Gonz\u00e1lez-Murillo","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.16_bib21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/gt.2011.195","article-title":"Evaluation of macrophage-specific promoters using lentiviral delivery in mice","volume":"19","author":"Levin","year":"2012","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.16_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2567.2001.01256.x","article-title":"The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo","volume":"103","author":"Gough","year":"2001","journal-title":"Immunology"},{"key":"10.1038\/mt.2015.16_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2002-07-2131","article-title":"Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector","volume":"101","author":"Gough","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib24","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1182\/blood-2014-04-568691","article-title":"Human CD68 promoter directs GFP transgene expression in mouse myeloid cells, allowing analysis of monocyte to macrophage differentiation in vivo","volume":"124","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib25","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"K\u00fchn","year":"1995","journal-title":"Science"},{"key":"10.1038\/mt.2015.16_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood.V100.2.560","article-title":"Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable","volume":"100","author":"Lev\u00e9en","year":"2002","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib27","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2003-04-1300","article-title":"TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro","volume":"102","author":"Larsson","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib28","first-page":"1","article-title":"An atlas and text of ultrastructural pathology","volume":"1987","author":"Phillips","year":"1987","journal-title":"Liver"},{"key":"10.1038\/mt.2015.16_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/hum.2013.171","article-title":"Efficiency and safety of O6-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model","volume":"25","author":"Phaltane","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.16_bib30","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/mtna.2014.51","article-title":"Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model","volume":"3","author":"Haemmerle","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mt.2015.16_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/hgtb.2012.175","article-title":"Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples","volume":"24","author":"Brugman","year":"2013","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2015.16_bib32","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.16_bib33","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.16_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.16_bib35","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.16_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/mt.2011.289","article-title":"Retroviral integrations in gene therapy trials","volume":"20","author":"Biasco","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.16_bib37","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2015.16_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mt.2010.226","article-title":"Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells","volume":"19","author":"Santilli","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.16_bib39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/gt.2011.65","article-title":"Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease","volume":"18","author":"Barde","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2015.16_bib40","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V81.6.1607.1607","article-title":"Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins","volume":"81","author":"Holness","year":"1993","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-3083.2008.02091.x","article-title":"Expression of CD68 in non-myeloid cell types","volume":"67","author":"Gottfried","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1038\/mt.2015.16_bib42","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1089\/hum.1998.9.17-2629","article-title":"Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation","volume":"9","author":"Dunbar","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.16_bib43","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.16_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymthe.2005.08.012","article-title":"Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells","volume":"13","author":"Schambach","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.16_bib45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1651-2227.1990.tb11492.x","article-title":"Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy","volume":"79","author":"Kyllerman","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"10.1038\/mt.2015.16_bib46","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2015.16_bib47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2012.192138","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry","volume":"59","author":"Gold","year":"2013","journal-title":"Clin Chem"},{"key":"10.1038\/mt.2015.16_bib48","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nmeth1103","article-title":"High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)","volume":"4","author":"Schmidt","year":"2007","journal-title":"Nat Methods"},{"key":"10.1038\/mt.2015.16_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/hum.2012.082","article-title":"High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias","volume":"24","author":"Wu","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.16_bib50","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/nprot.2010.87","article-title":"Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing","volume":"5","author":"Paruzynski","year":"2010","journal-title":"Nat Protoc"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T18:43:48Z","timestamp":1598726628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1525001616301083"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.16","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}